Viewing Study NCT04777851

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-01-27 @ 12:16 AM
Study NCT ID: NCT04777851
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-15
First Post: 2021-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7
Sponsor: Translational Research in Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Hepatocellular View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular Carcinoma View
None Hepatoma View
None Liver Cancer, Adult View
None Liver Cell Carcinoma View
None Liver Cell Carcinoma, Adult View